Found 7 matching trials
A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus PHASE1 This is a single center, randomised, double-blind, active comparator contro...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D PHASE2 This is a randomized, open-label, active-controlled, single-dose, 3-treatme...
Show More Location
World Wide Clinical Trials
Learn More & Join Trial
A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus PHASE1 This is a randomized, double-blind, active-controlled, 2 period cross-over ...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes PHASE4 This will be a randomized, open label, parallel group, multicenter study. T...
Show More Learn More & Join Trial
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes N/A This is an open label, observational study designed to collect data that ch...
Show More Learn More & Join Trial
A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus PHASE1 This trial is a monocentric, randomised, double-blind, active comparator, c...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes PHASE4 The purpose of this study is to evaluate the efficacy and safety of adding ...
Show More Learn More & Join Trial